Literature DB >> 23759526

Effects of chemically induced ovarian failure on voluntary wheel-running exercise and cardiac adaptation in mice.

Jessica N Perez1, Hao Chen, Jessica A Regan, Ashlie Emert, Eleni Constantopoulos, Melissa Lynn, John P Konhilas.   

Abstract

The role of exercise in decreasing the risk of cardiovascular disease in postmenopausal women has not been studied sufficiently. Accordingly, we investigated the effect of voluntary wheel-running and forced treadmill exercise on cardiac adaptation in mice treated with 4-vinylcyclohexine diepoxide (VCD), which selectively accelerates the loss of primary and primordial follicles and results in a state that closely mimics human menopause. Two-month-old female C57BL/6 mice injected with VCD (160 mg/kg) for 20 consecutive days underwent ovarian failure by 60 to 90 d after injection. Responses to voluntary wheel running and treadmill exercise did not differ between VCD- and vehicle-treated 7-mo-old C57BL/6 or outbred B6C3F1 mice. Moreover, adaptive cardiac hypertrophy, hypertrophic marker expression, and skeletal muscle characteristics after voluntary cage-wheel exercise did not differ between VCD- and vehicle-treated mice. Because 5' AMP-activated protein kinase (AMPK) is a key component for the maintenance of cardiac energy balance during exercise, we determined the effect of exercise and VCD-induced ovarian failure on the AMPK signaling axis in the heart. According to Western blotting, VCD treatment followed by voluntary cage-wheel exercise differently affected the upstream AMPK regulatory components AMPKα1 and AMPKα2. In addition, net downstream AMPK signaling was reduced after VCD treatment and exercise. Our data suggest that VCD did not affect exercise-induced cardiac hypertrophy but did alter cellular cardiac adaptation in a mouse model of menopause.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759526      PMCID: PMC3690429     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  53 in total

Review 1.  The relationship between obesity and breast cancer risk and mortality.

Authors:  Junaidah B Barnett
Journal:  Nutr Rev       Date:  2003-02       Impact factor: 7.110

2.  Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle.

Authors:  Jorgen F P Wojtaszewski; Christopher MacDonald; Jakob N Nielsen; Ylva Hellsten; D Grahame Hardie; Bruce E Kemp; Bente Kiens; Erik A Richter
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-12-17       Impact factor: 4.310

3.  The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats.

Authors:  T F Schaible; A Malhotra; G Ciambrone; J Scheuer
Journal:  Circ Res       Date:  1984-01       Impact factor: 17.367

4.  Regulation of LKB1 expression by sex hormones in adipocytes.

Authors:  K J McInnes; K A Brown; N I Hunger; E R Simpson
Journal:  Int J Obes (Lond)       Date:  2011-08-30       Impact factor: 5.095

5.  Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity.

Authors:  Gregory R Steinberg; Hayley M O'Neill; Nicolas L Dzamko; Sandra Galic; Tim Naim; René Koopman; Sebastian B Jørgensen; Jane Honeyman; Kimberly Hewitt; Zhi-Ping Chen; Jonathan D Schertzer; John W Scott; Frank Koentgen; Gordon S Lynch; Matthew J Watt; Bryce J W van Denderen; Duncan J Campbell; Bruce E Kemp
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

6.  Training effects in mice after long-term voluntary exercise.

Authors:  Sara R Davidson; Margaret Burnett; Laurie Hoffman-Goetz
Journal:  Med Sci Sports Exerc       Date:  2006-02       Impact factor: 5.411

7.  Effect of exercise intensity on skeletal muscle AMPK signaling in humans.

Authors:  Zhi-Ping Chen; Terry J Stephens; Sid Murthy; Benedict J Canny; Mark Hargreaves; Lee A Witters; Bruce E Kemp; Glenn K McConell
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

8.  Effects of exercise on protein synthesis and myosin heavy chain gene expression in hypothyroid rats.

Authors:  H L Katzeff; K M Ojamaa; I Klein
Journal:  Am J Physiol       Date:  1994-07

9.  Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Authors:  Alka M Kanaya; David Herrington; Eric Vittinghoff; Feng Lin; Deborah Grady; Vera Bittner; Jane A Cauley; Elizabeth Barrett-Connor
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

10.  Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system.

Authors:  Jazmin I Acosta; Loretta Mayer; Joshua S Talboom; Candy Wing S Tsang; Constance J Smith; Craig K Enders; Heather A Bimonte-Nelson
Journal:  Endocrinology       Date:  2009-05-21       Impact factor: 4.736

View more
  8 in total

1.  Diet and sex modify exercise and cardiac adaptation in the mouse.

Authors:  John P Konhilas; Hao Chen; Elizabeth Luczak; Laurel A McKee; Jessica Regan; Peter A Watson; Brian L Stauffer; Zain I Khalpey; Timothy A Mckinsey; Todd Horn; Bonnie LaFleur; Leslie A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-14       Impact factor: 4.733

2.  Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease.

Authors:  John P Konhilas; Jessica N Sanchez; Jessica A Regan; Eleni Constantopoulos; Marissa Lopez-Pier; Danielle K Cannon; Rinku Skaria; Laurel A McKee; Hao Chen; Yulia Lipovka; Dennis Pollow; Heddwen L Brooks
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

Review 3.  Molecular Mechanisms Underlying Cardiac Adaptation to Exercise.

Authors:  Rick B Vega; John P Konhilas; Daniel P Kelly; Leslie A Leinwand
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

Review 4.  The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic Syndrome.

Authors:  H L Brooks; D P Pollow; P B Hoyer
Journal:  Physiology (Bethesda)       Date:  2016-07

5.  Altered brain rhythms and behaviour in the accelerated ovarian failure mouse model of human menopause.

Authors:  Sophia Vrontou; Alexis Bédécarrats; Xiaofei Wei; Morikeoluwa Ayodeji; Attila Brassai; László Molnár; Istvan Mody
Journal:  Brain Commun       Date:  2022-06-22

6.  Anthracycline chemotherapy-mediated vascular dysfunction as a model of accelerated vascular aging.

Authors:  Zachary S Clayton; David A Hutton; Sophia A Mahoney; Douglas R Seals
Journal:  Aging Cancer       Date:  2021-06-22

7.  The clinical impact of estrogen loss on cardiovascular disease in menopausal females.

Authors:  Marissa A Lopez-Pier; Yulia Lipovka; Matthew P Koppinger; Preston R Harris; John P Konhilas
Journal:  Med Res Arch       Date:  2018-02-15

8.  Cardiac changes during the peri-menopausal period in a VCD-induced murine model of ovarian failure.

Authors:  Rosephine Del Fernandes; Alexandra Hall; Melissa Ferguson; Ilka Lorenzen-Schmidt; Vishali Balasubramaniam; W Glen Pyle
Journal:  Acta Physiol (Oxf)       Date:  2019-05-31       Impact factor: 6.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.